University of Maryland School of Medicine Researchers Receive NIH Grant to Develop Personalized Medicine Program for Genetic Types of Diabetes

June 18, 2014

Dr. Toni PollinGenomic screening will help detect often-misdiagnosed monogenic diabetes, tailor treatments and identify at-risk family members

Toni I. Pollin, M.S., Ph.D., a University of Maryland genetics researcher and lead investigator on the study.

The National Institutes of Health (NIH) has awarded a four-year, $3.7 million grant to researchers at the University of Maryland School of Medicine to develop a personalized medicine program to help doctors diagnose and treat monogenic diabetes – a form of diabetes caused by a mutation in a single gene. The study will evaluate methods to implement this program in various health care settings, with an objective to develop a model that could also be applied to caring for patients with genetic variations of other common diseases.


All active news articles